Financial markets were strong over the month of March, with international equities returning 3.2%, and fully NZD hedged international bonds gaining 0.9%. Markets pushed higher following the US Federal Reserve’s (the Fed) policy meeting mid-month. As widely anticipated, the Fed held interest rates steady for the fifth consecutive meeting. The market however, reacted positively to the Fed’s unadjusted expectation of 3 interest rate cuts later in the year, despite a recent uptick in inflation. This rally saw the leading markets in the US, the S&P 500 Index, and the Nasdaq Composite, hit new record highs.

Other share markets around the world also experienced strong returns. In Europe, markets gained as dovish signs from central banks encouraged a risk-on sentiment. Economic data also supported the push higher, as inflation continues to come off in the UK, decelerating from 4.0% in January to 3.4% in February, the lowest reading in more than 2 years. It wasn’t all positive news however, with confirmation that the UK entered a technical recession in the December 2023 quarter.

The Bank of Japan lifted interest rates for the first time in 17 years, seeing an end to its negative interest rate policy era that was established to fight chronic deflation. However, as accompanying comments reinforced, any removal of stimulus will be gradual, the move resulted in a weaker yen, strength in the share market and lower bond yields.

Looking at global equities from a sector perspective, the volatile energy sector was one of the leaders over March, as oil prices jumped on modestly better Chinese economic data and concerns over an escalation in tensions between Israel and Iran. While the technology sector lagged behind other sectors in March, it is still the best-performing sector so far in 2024.

Closer to home, the New Zealand economy, as expected, fell into technical recession. GDP in the December 2023 quarter fell 0.1%, marking a contraction in 4 out of the last 5 quarters. High inflation and interest rates continue to be a handbrake on the economy, which has seen a number of businesses struggle. Despite this, the domestic share market performed in line with its global counterparts and returned 3.1% over March.

marchinvestmentgraph

Note: Returns are in local currency terms.

After the strong start to the year for financial markets, especially international equities, the main challenge for investors is the now broad consensus that the benign macroeconomic conditions that have helped to drive these returns, will continue. While this does not necessarily suggest an impending equity market sell-off, and indeed equities could well continue rising, it does create a vulnerability should negative surprises arise. As such, we are comfortable maintaining a modestly cautious stance in the MAS Funds.

We have useful online tools to help you:

If you decide to change your fund after reviewing your risk profile or meeting with a MAS Adviser, you will need to complete an investment strategy change request form or for MAS Investment Funds investors, switch via the MAS Investor Portal:

There is no fee for switching.  

You can see weekly updates on fund unit prices and returns on our website:  

This article is of a general nature and is not a substitute for professional and individually tailored advice. Medical Funds Management Limited, JBWere (NZ) Pty Ltd and Bancorp Treasury Services Limited, their parent companies and associated entities do not guarantee the return of capital or the performance of investment funds. Returns indicated may bear no relation to future performance. The value of investments will fluctuate as the values of underlying assets rise or fall.  

MAS only provides advice on products offered by its subsidiary companies. Advice is provided by MAS or by its nominated representatives (who are all MAS employees). Our financial advice disclosure statement is available by visiting mas.co.nz or by calling 0800 800 627. 

The Product Disclosure Statement for the MAS KiwiSaver Scheme is available: KiwiSaver – MAS  

The Product Disclosure Statement for the MAS Retirement Savings Scheme is available: Retirement Savings Scheme – MAS  

The Product Disclosure Statement for the MAS Investment Funds is available: Investment Funds – MAS

Medical Funds Management Limited is the issuer and manager of the Schemes.  

More news

Join us for an in-person Member Connect function in May

15 April 2024 - All Members will receive an invitation to register for 1 of 5 functions across the country. Come learn about our new investment updates.

Medical students pull off pandemic-era conference

18 July 2022 - The organisers of the 2022 New Zealand Medical Students’ Association Conference believe the experience has taught them skills that will be invaluable to their medical careers.